[GRAPH] 20 Technologies Expected to Revolutionize the World of Medicine
By 2020, 20 billion devices are e...
Connectivity between patients and physicians is changing rapidly due to big data, connected devices and telemedicine.
By 2020, 20 billion devices are expected to be in use, with China operating 5.1 billion of them. The global big data market is also expected to generate revenue of over $122 billion by 2025.
The world of health care is slowly shifting to personalized care, with a focus on the individual rather than the masses.
Care is expected to become customized to best meet each individual’s needs, greatly enhancing the quality of health care. Care will be centered on the consumer, and electronic medical records are one source that will begin to drive this push forward.
Big data will allow for the compilation of a patient’s health history, the ability to transfer patient records in real time and allow physicians to correlate patient data and analyze regression rates to avoid premature releases when a patient is hospitalized.
Devices that allow individuals to track and share their health data with their physicians are on the rise. Apple’s latest Apple Watch and Philip’s prototype to aid those suffering from chronic illness are just two examples of wearable devices that will drive health care towards a brighter future.
Telemedicine consultations are expected to triple over the next year. And Google’s recent integration into the art is sure to skyrocket that number. Remote diagnostic screening has already become common in some countries and markets, and telesurgery may be next to appear in the industry.
The following infographic displays the technologies that will most impact both consumers and clinicians over the next five to 15 years.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”